Share

February 2017; 7 (1) Review

Aminopyridines for the treatment of neurologic disorders

Michael Strupp, Julian Teufel, Andreas Zwergal, Roman Schniepp, Kamran Khodakhah, Katharina Feil
First published November 10, 2016, DOI: https://doi.org/10.1212/CPJ.0000000000000321
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
523

Share

Article Information

vol. 7 no. 1 65-76
DOI: 
https://doi.org/10.1212/CPJ.0000000000000321
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received May 3, 2016
  • Accepted September 6, 2016
  • First Published November 10, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Michael Strupp, MD,
    2. Julian Teufel, MD,
    3. Andreas Zwergal, MD,
    4. Roman Schniepp, MD,
    5. Kamran Khodakhah, PhD and
    6. Katharina Feil, MD
  1. Michael Strupp, MD,
    2. Scientific Advisory Boards:

    1. Abbott, Actelion, Sensorion, Heel and Pierre-Fabre

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speaker honoraria from Solvay Pharmaceuticals, Inc. (now Abbott), GlaxoSmithKline, Merck Serono, HENNIG ARZNEIMITTEL GmbH & Co. KG, Pierre Fabre Laboratories, UCB,TEVA, Heel, Biogen Idec, and Eisai Inc.

    Editorial Boards:

    1. Joint-Chief Editor of the Journal of Neurology and Editor-in-Chief of Frontiers in Neuro-otology Section Editor of F1000

    Patents:

    1. NONE

    Publishing Royalties:

    1. Leitsymptom Schwindel Springer, Heidelberg 2012 Vertigo and dizziness - common complaints Springer, London, 2013 As Joint Chief-Editor of the Journal of Neurology

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Julian Teufel, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Andreas Zwergal, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Schwabe Pharma GmbH, speaker honorarium (2) Actelion Pharmaceuticals GmbH, speaker honorarium (3) Bayer Vital GmbH, speaker honorarium

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. The author was supported by the German Federal Ministry of Education and Health (BMBF) in connection with the foundation of the German Center for Vertigo and Balance Disorders (DSGZ) (grant number 01 EO 0901).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Roman Schniepp, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Kamran Khodakhah, PhD and
    6. Scientific Advisory Boards:

    1. Ataxion, Commercial

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Ataxion

    Research Support, Government Entities:

    1. NIH, PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Katharina Feil, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. University Hospital (MS, JT, AZ, RS, KF), Munich, Germany; and Albert Einstein College of Medicine (KK), New York, NY.
  1. Correspondence to:
    Michael.Strupp{at}med.uni-muenchen.de
View Full Text

Article usage

Article usage: November 2016 to April 2022

AbstractFullPdfSource
Nov 2016203012Highwire
Dec 2016221010Highwire
Jan 201724704Highwire
Feb 201710611255Highwire
Mar 201710111049Highwire
Apr 2017587313Highwire
May 2017288011Highwire
Jun 2017222114Highwire
Jul 20177025Highwire
Aug 20178706Highwire
Sep 20177135Highwire
Oct 20176906Highwire
Nov 20173903Highwire
Dec 201751917Highwire
Jan 20186724Highwire
Feb 20184846Highwire
Mar 20186267Highwire
Apr 20188209Highwire
Apr 2018223843pmc
May 201880110Highwire
Jun 2018127210Highwire
Jun 2018122629pmc
Jul 201816202Highwire
Aug 201813505Highwire
Aug 2018174039pmc
Sep 20183804Highwire
Oct 20188316Highwire
Nov 201892610Highwire
Dec 20187929Highwire
Jan 201965011Highwire
Feb 20195616Highwire
Mar 20194602Highwire
Apr 20195704Highwire
May 20195901Highwire
Jun 20198813Highwire
Jul 201913538Highwire
Aug 201912823Highwire
Sep 20196212Highwire
Oct 20196413Highwire
Nov 20197118Highwire
Dec 20197605Highwire
Jan 20208137Highwire
Feb 202012011Highwire
Mar 20207156Highwire
Apr 20205002Highwire
May 20205616Highwire
Jun 20206602Highwire
Jul 20202814Highwire
Aug 20202400Highwire
Sep 20206704Highwire
Oct 20205210Highwire
Nov 20204114Highwire
Dec 20203616Highwire
Jan 20212604Highwire
Feb 20214002Highwire
Mar 20213811Highwire
Apr 20212801Highwire
May 20214510Highwire
Jun 20212624Highwire
Jul 20213900Highwire
Aug 20215811Highwire
Sep 20213611Highwire
Oct 20215410Highwire
Nov 20212822Highwire
Dec 20216101Highwire
Jan 20224512Highwire
Feb 20223501Highwire
Mar 20224720Highwire
Apr 20224222Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me